A new pretreatment method termed solid-phase extraction (SPE) which is combined with dispersive liquid-liquid microextraction (SPE-DLLME) has been developed for the determination of oxazepam, alprazolam and diazepam in urine and plasma samples. The analytes were extracted from biological samples using SPE followed by DLLME. Various parameters that affect the efficiency of the two extraction techniques have been optimized. The calibration plots were linear in the range of 2.5-500 µg L of the SPE-DLLME-HPLC-UV as a sensitive method for the analysis of the targeted analytes in urine and plasma samples.
Introduction
Benzodiazepines (BZDs) constitute a class of versatile and widely prescribed CNS depressant, anxiolytics, sedative hypnotics, anticonvulsants and muscle relaxants (1) (2) (3) (4) . These drugs are frequently encountered in clinical and forensic toxicology having been featured in an increasing number of misuses and abuses over the past years (5, 6) .
BZDs may affect performances such as driving a vehicle or flying an aircraft (7, 8) . Their detection and quantification at a low level in biological fluids require reliable and sensitive methods.
Several methods have been reported for the analysis of BZDs. A number of chromatographic methods such as thin-layer chromatography (TLC) (9) , gas chromatography (10-12) and gas chromatographymass spectrometry (GC-MS) (13, 14) have been used in the analysis of BZDs. High-performance liquid chromatographic (HPLC) method has also been reported for the determination of BZDs (15) (16) (17) .
The analysis of BZDs in biological samples is preceded by sample preparation techniques such as liquid-liquid extraction (LLE) (18, 19) , solid-phase extraction (SPE) or solid-phase microextraction (20, 21) . However, these techniques can face challenges such as lengthy extraction time, large sample volumes and/or excess use of organic solvents (22) . Dispersive liquid-liquid microextraction (DLLME) was introduced by Rezaee and co-workers in 2006 (23) . In this method, an appropriate mixture of extraction and disperser solvents is used. This method has attracted a lot of attention due to advantages such as short extraction time, low consumption of organic solvent and simplicity (24) (25) (26) . Despite having some advantages, the DLLME method is not suitable for extracting BDZs compounds from the plasma, and an extra step is required for sample preparation. The application of the DLLME method in determining the presence of BDZs compounds in urine samples have been reported (27) . The SPE-DLLME is a combination technique that utilizes the advantages of both SPE and DLLME methods, such as simplicity, low solvent usage and exposure, low disposal costs and extraction time as well as high recovery and enrichment factor in complex matrices (28) (29) (30) (31) . The aim of this work was to combine the SPE and DLLME techniques in enhancing the selectivity of the DLLME method in the determination of BDZs compounds in complex matrix such as urine and plasma. In this work, the applicability of the SPE-DLLME technique in extracting some BDZ compounds in urine and plasma samples prior to their determination by HPLC was explored.
Experimental

Chemicals and reagents
Oxazepam, diazepam and alprazolam were obtained from SigmaAldrich (St. Louis, USA). Stock standard solutions of the analytes were prepared by dissolution of each drug in methanol, having a concentration of 250 mg L −1
. Fresh standard solutions were prepared by diluting the standard solution of the analytes with deionized water of required concentration. All these solutions were stored at 4°C in the absence of light. Carbon tetrachloride (GR), chloroform, dichloromethane, 1,2-dichloroethane, acetone, acetonitrile, ethanol, methanol and sodium chloride were obtained from Merck Company (Germany). The used water was purified on a Youngling Ultrapure Water Purification System (Aqua Max, Ultra, Korea). The urine from a healthy person was collected in disposable polyethylene containers and kept at 4°C before analysis. Frozen human plasma sample was obtained from the Iranian Blood Transfusion Organization (Tehran, Iran), thawed and allowed to reach room temperature.
Instrumentation
Chromatographic separations were carried out on Waters' breeze with 1525 Binary HPLC pump (Massachusetts, USA) and 20 µL loop sample equipped with 2487 UV/Vis Waters' detector. Separations were carried out on Waters' Spherisorb ODS2 column (250 mm × 4.6 mm, with 5.0 µm particle size; Waters Company, Massachusetts, USA). A mixture of water and acetonitrile (55:45) at a flow rate of 1 mL min −1 was used as a mobile phase in the isocratic elution mode. The injection volume was 20 µL for all the samples, and the determination was performed at the wavelength of 230 nm.
SPE-DLLME procedure SPE of BZDs from the samples was carried out using C 18 sorbent (3 mL syringe barrel, Waters, USA). The sorbent was conditioned with 2.0 mL of acetone. The sample was passed through the column at a flow rate of 6.7 mL min −1
. Thereafter, the column was dried under vacuum. The targeted analytes were subsequently eluted with 1.5 mL ethanol, and the eluent solution was collected and used as disperser solvent in the subsequent DLLME procedure. An aqueous solution (5.0 mL) was placed in a 10 mL screw cap glass test tube with a conical bottom. Ethanol (disperser solvent; 1.5 mL) containing 112.0 µL dichloromethane (extraction solvent) was injected rapidly into the aqueous solution. A cloudy solution, resulting from the dispersion of the fine dichloromethane droplets, was formed in the test tube. After extracting for a few seconds, the mixture was then centrifuged for 3 min at 3,000 rpm. The dispersed fine dichloromethane droplets were deposited at the bottom of the conical test tube. The sedimented phase was completely transferred into another test tube with a conical bottom using 50 µL HPLC syringe. After evaporation of the solvent in a water bath, the residue was dissolved in 20 µL HPLC grade methanol and was injected into the separation system.
Results
In this study, SPE-DLLME-HPLC-UV method was applied for the determination of BZDs compounds in biological samples. To achieve a higher extraction recovery (ER) and enhanced preconcentration factor (PF), the SPE and DLLME conditions were optimized. To obtain the best extraction performance, different parameters affecting the extraction process such as the kind and volume of extraction and disperser solvents, flow rate of the sample solution, and addition of salt to the sample were studied and optimized.
Effect of type and volume of the extraction solvent
Careful attention should be paid to the selection of the extraction solvent. The extraction solvent must have high extraction capability for the analytes and low solubility in water. In addition, due to the low volume used, and to facilitate its collection (20 µL) at the bottom of the conical test tube, the extraction solvent must have a higher density than water. Considering these features, carbon tetrachloride (CCl 4 ), dichloromethane (CH 2 Cl 2 ), chloroform (CHCl 3 ) and 1,2-dichloroethane were studied. The physicochemical properties of these extraction solvents are recorded in Table I . Sample solutions were tested using 1.0 mL acetone and different volumes of the extraction solvents to achieve a 20 µL volume of the sedimented phase. As shown in Table II , dichloromethane possessed the highest extraction recovery compared with the other extraction solvents. Therefore, dichloromethane was selected as the extraction solvent in the subsequent experiments.
To examine the effect of the extraction solvent volume, 1 mL of acetone containing different volumes of dichloromethane (102.0, 120.0, 135.0, 150 and 165 µL) was subjected to the same SPE-DLLME procedure. As shown in Figure 1 , the preconcentration factor decreased with an increase in the volume of the extraction solvent, because the volume of the settled phase increased with an increase in the volume of dichloromethane. Therefore, 102.0 µL of dichloromethane was selected as the optimized volume of the extraction solvent.
Effect of type and volume of disperser solvent
The main criterion for selecting the disperser solvent was its miscibility with the extraction solvent and aqueous sample. For this purpose, different solvents such as acetonitrile, ethanol, methanol and acetone were examined. The extraction was performed using 1.0 mL of each disperser solvent containing 102.0 µL dichloromethane. Table III indicates that ethanol exhibits the highest extraction efficiency. Thus, ethanol was selected as the disperser or eluent solvent in the subsequent experiments.
To study the effect of disperser solvent volume, the volume of the sedimented phase was kept constant (20 µL). Different volumes of ethanol (0.5, 1.0, 1.5 and 2.0 mL) with 92.0, 102.0, 112.0 and 122.0 µL of dichloromethane were used. It is clear from Figure 2 that 1.5 mL ethanol had the highest recovery. It seems that, at the volume of 1.5 mL, the amount of ethanol was enough for effective elution of the selected analytes. At a low volume of ethanol, cloudy solution was not properly formed resulting in a decrease in the extraction recovery. At a high volume of ethanol, the solubility of the analytes in the sample increased resulting in a decrease in extraction efficiency. Thus, 1.5 mL was selected as the optimum volume of ethanol.
Effect of the flow rate of the sample solution
The flow rate of the sample solution through the SPE column controls the analytical time and affects the retention capacity of the analytes. The flow rate must be high enough to reduce the analytical time.
On the other hand, it must be slow enough to perform an effective retention of the analytes. Therefore, the optimized flow rate should consider the two factors mentioned previously. The effect of flow rate on recoveries of three BDZs was investigated in the range of 0.65-8.6 mL min −1 . Figure 3 shows that the analyte recoveries did not change significantly from the range of 0.65-6.7 mL min −1 , although an increase in the flow rate decreased the recovery. Therefore, 6.7 mL min −1 was selected as the optimized flow rate.
Effect of salt
The influence of ionic strength was evaluated at 0-8% (w/v) NaCl.
The experimental results showed that the addition of salt had no significant effect on the extraction efficiency of the analytes. This is probably due to the opposite effects of the addition of salt. One is to increase the volume of the sedimented phase and dilution effect, this reduces the extraction efficiency; another is the salting out effect, that increases the extraction efficiency. It is to be noted that by increasing the salt concentration, the volume of the sedimented phase increased, due to the decrease in the solubility of the extraction solvent. Therefore, the following experiments were carried out without the addition of salt.
Discussion
Quantitative aspects
As summarized in Table IV , the calibration curve was obtained under the optimized SPE-DLLME-HPLC-UV conditions. For urine samples, the linearity of calibration curve was observed in the range of 1.0-500 µg L (32, 33) . The dynamic linear range and LODs of the proposed method were better than the obtained results of DLLME (27) method for urine samples.
Simultaneously, three methods, including SPE, DLLME and SPE-DLLME, were used for the determination of the analytes in urine and plasma samples. To use the DLLME method, the plasma sample was dissolved in acetonitrile, and then centrifuged and filtered. Finally, the relatively clear solution obtained was diluted in the ratio of 1:10. Therefore, more dilution in biological fluids is required in comparison to the proposed method that causes problems in trace detection. However, by using SPE combined with DLLME, by just dissolving plasma in acetonitrile is enough to achieve sufficient results. Therefore, by using hyphenated technique, the need for dilution (1:10) is omitted and the possibility for trace-level analysis is provided. To remove the matrix effect in the DLLME method and achieve good relative recovery in the urine sample, it should be diluted to 1:5. However, dilution to 1:1 is enough for removing the interference effect in the SPE-DLLME of urine sample. This is related to the clean-up property of the SPE method in the hyphenated technique. The dynamic linear range of the DLLME method in urine and plasma were 2.0-500 and 10-500 µg L −1 , respectively. The LODs of the DLLME method in urine and plasma samples were in the range of 0.3-0.7 and 2.1-6.3 µg L −1 , respectively. The RSDs of the DLLME method in urine and plasma were in the range 5.5-8.3 and 11.5-16.3%, respectively. As can be seen in Table VI , the dynamic linear range and LODs of the proposed method are better than those of the DLLME method in urine and plasma samples. In addition, the RSDs of the proposed method were better than the obtained results for the DLLME method in urine and plasma samples. Comparison of the proposed method with the SPE method without DLLME procedure, also shows the superiority of the hyphenated technique. The calibration graphs were in the range of 10-500 µg L −1 in urine and 20-500 µg L −1 in plasma using the SPE method. It was shown that by combining SPE with the DLLME procedure, the preconcentration factor increased because of the large surface area between the extraction solvent and the selected analytes. The LODs of the SPE method in urine and plasma samples were in the range of 2.5-5.0 and 7.4-10.7 µg L −1
, respectively. The RSDs of the SPE method in urine and plasma samples were in the range of 10.1-14.3 and 11.2-18.6%, respectively. Therefore, the LODs and RSDs of the proposed method were better than those of the SPE method in urine and plasma samples.
Finally, diazepam, oxazepam and alprazolam as BZDs drugs, which are illicit drugs with zero tolerance acceptability. Their detection and quantification at low levels in biological fluids require reliable and sensitive methods. The proposed method has great potential in determining the selected analytes at trace levels in biological fluids.
Analysis of urine and plasma samples
The proposed SPE-DLLME technique was applied to determine the BDZ compounds in urine and plasma samples to elucidate the applicability and reliability of the method. The urine sample was diluted to 1:1 using deionized water to reduce the matrix effect. To use the SPE-DLLME method for the plasma samples and to reduce the matrix effect, human plasma was dissolved in acetonitrile (1:1, (v/v)). The spiking recoveries of the target compounds in the urine and plasma 
where C found , C real and C added are the concentrations of the analytes after the addition of a known amount of standard in a real sample, the concentration of the analytes in a real sample and the concentration of a known amount of standard, which was spiked to the real sample, respectively. The RRs were between 84 and 95.5% (Table VII) , and these RR values showed that the matrix had a negligible effect on the performance of the proposed method. The chromatograms of the plasma samples before and after spiking at the concentration 5.0 µg L −1 are shown in Figure 4 .
Conclusion
In this study, SPE clean-up combined with DLLME has been developed as a new approach for extracting oxazepam, alprazolam and diazepam in urine and plasma samples by HPLC analysis. The combination of SPE with DLLME makes it possible for the selective determination of trace analytes in complex matrices. The evaluation of the analytical performance of the proposed method provided satisfactory linearity, precision and detection limits, and it was successfully applied in the analysis of real samples. Therefore, it has the potential 
